Qritive Pte. Ltd. is now ISO/IEC 27001:2022 certified

Singapore, October 10, 2024 — This certification is a testament to our commitment to maintaining the highest standards of information security management. It specifically applies to our AI-based pathology diagnostic solutions developed as Software as a Medical Device and for data and information handling within Qritive. Our journey towards this achievement underscores our dedication to ensuring the utmost security and integrity of our systems and data. As we continue to innovate and lead in the field of AI-based diagnostics, this certification reaffirms our pledge to deliver reliable and secure solutions to our valued clients and partners. We extend our gratitude to our incredible team whose hard work and dedication made this possible. Here’s to setting new benchmarks in the industry and continuing to provide top-notch solutions in the realm of digital pathology.

About Qritive

Qritive, headquartered in Singapore with operations in the US and India, is transforming digital pathology through advanced AI-powered solutions that support cancer diagnosis and improve health outcomes.

By leveraging cutting-edge deep learning technology, Qritive supports pathologists in the interpretation of pathology assessments and enhances pathology workflows—enabling faster, more accurate diagnoses and reducing time to treatment.

Qritive is committed to empowering healthcare professionals around the world with tools that promote collaboration and high performance, regardless of complexity or distance.

Get in Touch

Want to learn more about our solutions or explore potential collaborations?

Visit www.qritive.com or contact us at info@qritive.com